3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
224
Rectal Neoplasms
124
Colonic Neoplasms
120
Stomach Neoplasms
60
Pancreatic Neoplasms
58
Neoplasm Metastasis
48
Lymphoma
39
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Leukemia
32
Esophageal Neoplasms
32
Neoplasms
31
Burkitt Lymphoma
19
Adenocarcinoma Of Esophagus
17
Adenocarcinoma
17
Carcinoma, Hepatocellular
13
Lymphoma, Non-Hodgkin
12
Lymphoma, Large B-Cell, Diffuse
12
Unspecified Adult Solid Tumor, Protocol Specific
11
Biliary Tract Neoplasms
11
Lymphoma, Mantle-Cell
10
Gallbladder Neoplasms
10
Liver Neoplasms
9
Osteosarcoma
8
Lymphoma, Large-Cell, Immunoblastic
8
Gastrointestinal Neoplasms
8
Bile Duct Neoplasms
8
Lymphoma, Follicular
7
Dendritic Cell Sarcoma, Interdigitating
7
Cholangiocarcinoma
7
Leukemia, Myeloid, Acute
6
Interventions
pembrolizumab
3
Nivolumab
2
vicriviroc
1
relatlimab
1
copanlisib
1
binimetinib
1
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Spinocerebellar Degenerations
×
Leucovorin
×
Clear all
NCT03374254
2024-11-21
KEYNOTE-651
Merck Sharp & Dohme LLC
Phase 1
Completed
116 enrolled
18 charts